THE DEAL, AT A GLANCE
From the announcementEmboline
01What happenedEmboline raised $55M Series DFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Why it mattersEmboline is using Series D capital to move the Emboliner™ catheter through an FDA clinical study and toward market launch for stroke-risk reduction in TAVR procedures.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Emboline · Financing Record
Explore source-linked visual explanations for Emboline. Unsupported claims are withheld while source review continues.
Record 2070 · Recorded date: Needs review
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →